Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Ekso Bionics Holdings, Inc. (EKSO)

1.17   0.01 (0.86%) 11-28 09:41
Open: 1.17 Pre. Close: 1.16
High: 1.17 Low: 1.13
Volume: 5,372 Market Cap: 15(M)

Technical analysis

as of: 2022-11-28 9:18:06 AM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.72     One year: 1.96
Support: Support1: 1.13    Support2: 0.94
Resistance: Resistance1: 1.47    Resistance2: 1.67
Pivot: 1.34
Moving Average: MA(5): 1.23     MA(20): 1.4
MA(100): 1.77     MA(250): 2.16
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 1.7     %D(3): 3.4
RSI: RSI(14): 29.5
52-week: High: 3.49  Low: 1.13
Average Vol(K): 3-Month: 30 (K)  10-Days: 39 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ EKSO ] has closed above bottom band by 5.6%. Bollinger Bands are 13.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.25 - 1.26 1.26 - 1.27
Low: 1.12 - 1.13 1.13 - 1.14
Close: 1.15 - 1.16 1.16 - 1.17

Company Description

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.

Headline News

Mon, 28 Nov 2022
Intelligent Soft Robotic Market Size and Landscape Outlook, Revenue Growth Analysis to 2028 – Cyberdyne Inc.,Ekso Bionics Holdings,Empire Robotics - Digital Journal

Mon, 28 Nov 2022
With Market Valuation of US$ 8 Billion Exoskeleton Robots Market is forecasted to Skyrocket at an Impressive CAGR Of 23.7%: Fact.MR Report - EIN News

Sun, 27 Nov 2022
Home Rehabilitation Market 2022 key developmental strategies implemented by the key players:Stryker, Handicare, Invacare, DJO, Hocoma, Ekso Bionics, RehabCare, AliMed, Ergoline, Performance Health, Medline Industries, Patterson Medical Holdings, Pri - Skegness Siren

Sat, 26 Nov 2022
Humanoid Healthcare Assistive Robot Market Statistical Forecast, Trade Analysis 2022 –Barrett Technology, Cyberdyne, Ekso Bionics, Gait Tronics, Hansen, Hocoma, HONDAMotor, Interactive Motion, Companynine, Kinova Robotics, KUKARobot, ReWalkRo - Skegness Siren

Fri, 25 Nov 2022
2022 Human Augmentation Market Share, Size, Trends Report: Increasing Adoption of Wearable Augmentation Products and Increased Understanding of the Therapeutic Benefits - ResearchAndMarkets.com - Business Wire

Sun, 13 Nov 2022
Wearable Medical Robot Market Forecast, Trend Analysis To 2028 |Intuitive Surgical, Ekso Bionics Holdings, TransEnterix, Verb Surgical – The C-Drone Review - The C-Drone Review

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 13 (M)
Shares Float 12 (M)
% Held by Insiders 8 (%)
% Held by Institutions 16.5 (%)
Shares Short 61 (K)
Shares Short P.Month 85 (K)

Stock Financials

EPS -0.93
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.18
Profit Margin (%) -109.9
Operating Margin (%) -116.7
Return on Assets (ttm) -21.8
Return on Equity (ttm) -43.7
Qtrly Rev. Growth 9.1
Gross Profit (p.s.) 0.51
Sales Per Share 1.02
EBITDA (p.s.) -1.17
Qtrly Earnings Growth 0
Operating Cash Flow -14 (M)
Levered Free Cash Flow -8 (M)

Stock Valuations

PE Ratio -1.26
PEG Ratio 0
Price to Book value 0.53
Price to Sales 1.13
Price to Cash Flow -1.08

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2020-03-24
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.